Mass versus molar doses, similarities and differences

Pharmazie

Volumn 63, Issue 11, 2008, Pages 843-848

  Chmielewska, Aleksandra ^a   Lamparczyk, H ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID DERIVATIVE; ALFACALCIDOL; ANALGESIC AGENT; ANTIBIOTIC AGENT; ATENOLOL; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEZAFIBRATE; CALCIUM CHANNEL BLOCKING AGENT; CIPROFIBRATE; CYCLOOXYGENASE 2 INHIBITOR; ERYTHROMYCIN; ESTROGEN DERIVATIVE; ETODOLAC; FELODIPINE; FIBRIC ACID DERIVATIVE; GABAPENTIN; GEMFIBROZIL; HYDROCHLOROTHIAZIDE; NEUROLEPTIC AGENT; NICOTINIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; NOOTROPIC AGENT; ORAL CONTRACEPTIVE AGENT; PIRACETAM; TEMAZEPAM; UNINDEXED DRUG; VITAMIN; ZOPICLONE;

ARTICLE; DOSE CALCULATION; DRUG ACTIVITY; DRUG RELEASE; OUTCOME ASSESSMENT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

CHEMISTRY, PHARMACEUTICAL; CONTRACEPTIVES, ORAL; DRUG COMBINATIONS; HYDROCHLOROTHIAZIDE; MASS SPECTROMETRY; PHARMACEUTICAL PREPARATIONS;

EID: 56749095474     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2008.8578     Document Type: Article

References (25)

1. Bachmann G, Sulak PJ, Sampson-Landers C, Benda N, Marr J (2004) Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirone. Contraception 70: 191-198.
2. Chamberlain DA, Clark AJ, Sheldon J (1976) Letter to the Editor. Br Med J 30 October: p 1068.
3. Chen CY, Lu CL, Luo JC, Chang FY, Lee SD, Lai YL (2005) Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis. World J Gastroenterol 11: 3112-3117.
4. Clancy L, Goodman P, Sinclar H, Dockery DW (2002) Effect of air-pollution control on death rates in Dublin, Ireland: an intervention study. Lancet 360: 1210-1214.
5. Cnota PJ, Nowak H., Tagarro I, Erb K, Schurer M, Schulz HU, Maus J (2005) Tramadol SR formulations: Pharmacokinetic comparison of a multiple units dose (capsule) versus a single unit dose (tablet). Clin Drug Investig 25: 435-443.
6. Cui D, Tian F, Ozkan CS, Wang M, Gao H (2005) Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol Lett 155: 73-85.
7. D'Cruz OJ, Uckun FM (2001) Short-term (13-week) toxicity study of 5-bromo-6-methoxy-5,6-dihydro-3′azidothymidine-5′-(p-bromophenyl) methoxyalanil phosphate (WHI-07), a novel anti-HIV and contraceptive agent, in B6C3F1 mice. Toxicological Sciences 60: 373-378.
8. Emerich DF, Thanos CG (2006) The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol Engin 23: 171-184.
9. Evans AM (1996) Pharmacodynamics an pharmacokinetics of the profens: enantioselectivity, clinical implications and, special reference to S(+) ibuprofen. J Clin Pharmacol 36: 7S-15S.
10. Kahn LS, Halbreich U (2001) Oral contraceptives and mood. Expert Opin Pharmacother 2: 1367-1382.
11. Kipen HM, Laskin DL (2005) Smaller is not always better: nanotechnology yields nanotoxicology. Am J Physiol Lung Cell Mol Physiol 289: L696-L697.
12. Lamparczyk H, Zarzycki PK Nowakowska J (1994) Effect of temperature on separation of Norgestrel enantiomers by high-performance liquid chromatography. J Chromatogr A 668: 469-473.
13. Mamidi RN, Mullangi R, Kota J, Bhamidipati R, Khan AA, Katneni K, Datla S, Singh SK, Rao KY, Rao CS, Srinivas NR, Rajagoplan R (2002) Pharmacological and pharmacokinetic evaluation of celecox prodrugs in rats. Biopharm Drug Disp 23: 273-282.
14. Medina C, Santos-Martines MJ, Radomski A, Corrigan OI, Radomski MW(2007) Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 150: 552-558.
15. Oberdorster E (2004) Manufactures nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect 112: 1058-1062.
16. Peres M, Cardenas W, Ramires G, Peres M, Restrepo P ( 2006) A comparative, cross-over, double blind, randomized study for bioequivalence assessment between two formulations of valsartan capsules vs tablets. Colombia Med 37: 114-120.
17. Richter K, Kanniess F, Biberger C, Nave R, Magnussen H (2005) Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patient with asthma. J Clin Pharmacol 45: 146-152.
18. Roden SM, Mander GA (1976) Molar dosage of calcium chloride. Br Med. J 20 November: p. 1255.
19. Shah J, Wesnes KA, Kovelesky RA, Henney HR (2006) Effects of food on the single-dose pharmacokinetics/pharmacodynamics of thiazanidine capsules and tablets in healthy volunteers. Clinical Therap 20: 1308-1317.
20. Schall R, Muller FO, Duursema L, Groenewoud G, Hundt HK, Middle MV, Mogilnicka EM Swart KJ (1995) Relative bioavailability of rifampicin, izoniazid and ethambutol from a combination tablet vs. concomitant administration of a capsule containing rifampicin and a tablet containing isoniazid and ethambutol. Arzneimittelforschung 45: 1236-1239.
21. Staels B, Dallongeville J, Auverx J, Schoonjans K, Leitersdorf E, Fruchart JC (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98: 2088-2093.
22. Stone S (1993) Clinical review of a monophasic oral contraceptive containing desogestrel and ethinylestradiol. Int J Fertil Menopausal Stud 38 suppl: 117-121.
23. Wysocki J, Belowski D, Kalina M, Kochanski L, Okopien B, Kalina Z (2004) Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome. Int J Clin Pharmacol Ther 42: 212-217.
24. Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A (2005) Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstetr Gynecol 106: 492-501.
25. Zarzycki PK, Nowakowska J, Chmielewska A, Wierzbowska M, Lamparczyk H (1997) Thermodynamic study of the retention behaviour of selected macrocycles using reversed phase high-performance thin-layer chromatography plates and metanol-water mobile phases. J Chromatogr A 787: 227-233.